Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Staff Reporters
***
***
The FDA has approved a new gene therapy to treat hemophilia B, a genetic bleeding disorder. The drug maker CSL Behring set a $3.5 million price for the one-time treatment.
***
The recent stock choppiness has come amid uncertainty regarding the ultimate economic impact of aggressive rate hikes, of which inflation has been a primary driver of the tightening. More key inflation data is on tap next week, courtesy of the Consumer Price Index (CPI) and the Import Price Index. These reports will lead up to the Federal Open Market Committee’s (FOMC) long-awaited monetary policy decision that will be released on Wednesday.
In other economic news, a preliminary look at consumer sentiment surprised to the upside. On the equity front, Lululemon Athletica beat top and bottom line estimates but lowered its guidance, RH also bested forecasts though warned of worsening demand moving forward, Broadcom posted upbeat results and increased its dividend, and Microsoft is now facing a U.S. government antitrust lawsuit in its attempt to acquire Activision Blizzard.
Treasury yields rose following the wholesale price data, and the U.S. dollar gained modest ground, while crude oil prices dipped, and gold increased.
Asian stocks finished higher with Hong Kong markets leading the way, and European stocks gained ground as the global markets absorbed inflation data out of the U.S. and China.
***
***
COMMENTS APPRECIATED
Thank You
***
Share this:
Filed under: Alerts Sign-Up, Alternative Investments, Drugs and Pharma, Investing, LifeStyle | Tagged: hemophilia B, inflation, stocks down, Wholesale Price Inflation Up, WPI |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Leave a Reply